TOKYO – Japan's National Cancer Center (NCC) and pharma major Takeda Pharmaceutical Co. Ltd. have joined forces to discover and develop cancer drugs in Japan and ensure their quick delivery to patients.
TOKYO – Japan’s National Cancer Center (NCC) and pharma major Takeda Pharmaceutical Co. Ltd. have joined forces to discover and develop cancer drugs in Japan and ensure their quick delivery to patients.
TOKYO – Two biotech companies from Japan are pooling complementary resources and products to tackle the rising incidence of dementia in a country with an aging population.
TOKYO – Two biotech companies from Japan are pooling complementary resources and products to tackle the rising incidence of dementia in a country with an aging population.
TOKYO – Japan is taking further steps to speed up reviews of innovative new drug and medical device applications through a new Sakigake designation. Sakigake roughly translates into "leading the way."